Addition of Ipatasertib to Dual Anti-HER2 Maintenance Therapy in HER2-Positive Metastatic Breast Tumors with PIK3CA Mutations: The Phase Ib SOLTI-1507 IPATHER Trial
在 PIK3CA 突变的 HER2 阳性转移性乳腺癌中,将 Ipatasertib 加入双重抗 HER2 维持治疗:Ib 期 SOLTI-1507 IPATHER 试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-2298
Oliveira, Mafalda; Ciruelos, Eva; Villacampa, Guillermo; Morales, Serafín; Salvador Bofill, Javier; Quiroga, Vanesa; Gavilá, Joaquín; Cortegoso, Alexandra; Vega, Estela; Henao, Fernando; Servitja, Sonia; Tolosa, Pablo; Chillara, Samyukta; Bergamino, Milana; Salvador, Fernando; Paes Dias, Mariana; Ferrero-Cafiero, Juan M; Gonzalez Farre, Xavier; Pascual, Tomás; Saura, Cristina